WW International heads into the week with an activist on its doorstep and shorts still deeply embedded after last week's earnings punishment.
The timing of the Galloway Capital Partners move is striking. The firm filed a Schedule 13D today — May 13 — disclosing an 8.42% stake in the company. That arrival follows a brutal Q1 earnings print on May 7, when subscribers continued to decline and an EBITDA loss was confirmed, sending shares down 13.6% in a single session. The stock has now fallen 19% on the week to $9.64 and is down 10% over the past month. With a market cap of roughly $96 million, even a modest activist position commands real leverage at the table.
The short position tells its own story, and it is a large one. Short interest is running at nearly 24% of the free float — a level that has been structurally elevated throughout April and May, rising sharply from around 18.5% in mid-April to a peak near 26.7% on May 5 before settling back slightly. The official FINRA figure puts days to cover at 4.75. Borrowing, however, remains surprisingly easy: cost to borrow is a modest 0.87%, down sharply from the 1.4% range seen in early April, and availability is at 125% of short interest — meaning there are more shares still available to borrow than are currently short. That combination of high short interest and loose borrow conditions suggests the short book is well-established and uncrowded rather than under squeeze pressure. Shares availability is well above the tight threshold; there is no structural scarcity of borrows here.
Options positioning tells a sharply different story from the shorts. The put/call ratio has collapsed to 0.14 — nearly two standard deviations below its 20-day average of 0.21, making this the most call-skewed reading in recent memory against a 52-week low of 0.0. That is a jarring contrast: options traders are piling into calls while short sellers remain heavily positioned on the other side. The most obvious explanation is that the Galloway 13D, or anticipation of activist activity, has attracted speculative call buying. Squeeze dynamics are not yet reflected in borrow costs, but the call volume is worth watching.
The ORTEX short score of 73.5 — in the 6th percentile of all stocks on the short-score rank — flags this as one of the more structurally shorted names in the universe, though the score has drifted slightly from its recent peak of 75.5 on May 5. Valuation offers limited comfort: the EV/EBITDA is 3.8x, which appears optically cheap but is complicated by negative earnings (the PE is deeply negative at around -5.2x). The EPS momentum factor scores are violently split — 30-day momentum ranks in the 99th percentile, while 90-day momentum sits at the 1st percentile — a reflection of the whipsaw nature of estimates around a restructuring story. Morgan Stanley has maintained an Equal-Weight rating and lowered its target to $34.50 in January 2026; that target is now more than three times the current $9.64 price, which flags the severity of the derating this year. The analyst data is otherwise thin and should be treated cautiously.
Institutional ownership is concentrated. Aristeia Capital holds 9.2% and is now joined by Galloway's 8.42%. Millennium Management and Cooper Creek also have material positions. The top five holders collectively account for roughly 35% of shares outstanding — a small-cap register where a motivated activist can move quickly. The next earnings event is scheduled for June 12. Between now and then, the Galloway filing is likely to dominate the narrative: what the firm wants, at what price, and whether a heavily shorted stock with call-skewed options and a tightly held register starts to behave differently than it has all spring.
See the live data behind this article on ORTEX.
Open WW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
